Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'HUMANIZED ANTIBODY' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 106 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Wedderburn, LR; Jeffery, R; White, H; Patel, A; Varsani, H; Linch, D; Murray, K; Woo, P
      Autologous stem cell transplantation for paediatric-onset polyarteritis nodosa: changes in autoimmune phenotype in the context of reduced diversity of the T- and B-cell repertoires, and evidence for reversion from the CD45RO(+) to RA(+) phenotype

      RHEUMATOLOGY
    2. Liu, G
      Small molecule antagonists of the LFA-1/ICAM-1 interaction as potential therapeutic agents

      EXPERT OPINION ON THERAPEUTIC PATENTS
    3. King, KA; Hu, CP; Rodriguez, MM; Romaguera, R; Jiang, XB; Piedimonte, G
      Exaggerated neurogenic inflammation and substance p receptor upregulation in RSV-infected weanling rats

      AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
    4. Reff, ME; Heard, C
      A review of modifications to recombinant antibodies: attempt to increase efficacy in oncology applications

      CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
    5. Gieseg, MA; de Bock, C; Ferguson, LR; Denny, WA
      Evidence for epidermal growth factor receptor-enhanced chemosensitivity incombinations of cisplatin and the new irreversible tyrosine kinase inhibitor CI-1033

      ANTI-CANCER DRUGS
    6. Leyland-Jones, B; Arnold, A; Gelmon, K; Verma, S; Ayoub, JP; Seidman, A; Dias, R; Howell, J; Rakhit, A
      Pharmacologic insights into the future of trastuzumab

      ANNALS OF ONCOLOGY
    7. Scholl, S; Beuzeboc, P; Pouillart, P
      Targeting HER2 in other tumor types

      ANNALS OF ONCOLOGY
    8. Takai, T; Takahashi, K; Akagawa-Chihara, M; Fukada, M; Yuuki, T; Shibuya, I; Okumura, K; Ra, C; Yokota, T; Okumura, Y
      Production of humanized antibody against human high-affinity IgE receptor in a serum-free culture of CHO cells, and purification of the Fab fragments

      BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY
    9. Nakamura, K; Tanaka, Y; Shitara, K; Hanai, N
      Construction of humanized anti-ganglioside monoclonal antibodies with potent immune effector functions

      CANCER IMMUNOLOGY IMMUNOTHERAPY
    10. Parajuli, P; Yanagawa, H; Hanibuchi, M; Takeuchi, E; Miki, T; Yano, S; Sone, S
      Humanized anti-ganglioside GM2 antibody is effective to induce antibody-dependent cell-mediated cytotoxicity in mononuclear cells from lung cancer patients

      CANCER LETTERS
    11. Lee, FT; Hall, C; Rigopoulos, A; Zweit, J; Pathmaraj, K; O'Keefe, GJ; Smyth, FE; Welt, S; Old, LJ; Scott, AM
      Immune-PET of human colon xenograft-bearing BALB/c nude mice using I-124-CDR-grafted humanized A33 monoclonal antibody

      JOURNAL OF NUCLEAR MEDICINE
    12. Chau, LA; Tso, JY; Madrenas, J
      Generation of partial agonist ligands of the T-cell receptor by engineering of antibodies against CD3

      TRANSPLANTATION PROCEEDINGS
    13. Bumgardner, GL; Hardie, I; Johnson, RWG; Lin, A; Nashan, B; Pescovitz, MD; Ramos, E; Vincenti, F
      Results of 3-year phase III clinical trials with daclizumab prophylaxis for prevention of acute rejection after renal transplantation.

      TRANSPLANTATION
    14. Leyland-Jones, B
      Dose scheduling - Herceptin (R)

      ONCOLOGY
    15. Fishman-Lobell, J; Tsui, P; Reddy, M; DiPrinzio, R; Eichman, C; Sweet, RW; Truneh, A
      CD4 mAb induced apoptosis of peripheral T cells: multiparameter subpopulation analysis by flow cytometry using Attractors (TM)

      JOURNAL OF IMMUNOLOGICAL METHODS
    16. Takai, T; Okumura, K; Ra, C; Yokota, T; Okumura, Y
      Expression of humanized fab fragments that recognize the IgE-binding domain of human Fc epsilon RI alpha in COS and CHO cells

      JOURNAL OF BIOCHEMISTRY
    17. Winquist, RJ; Desai, S; Fogal, S; Haynes, NA; Nabozny, GH; Reilly, PL; Souza, D; Panzenbeck, M
      The role of leukocyte function-associated antigen-1 in animal models of inflammation

      EUROPEAN JOURNAL OF PHARMACOLOGY
    18. Kim, NS; Lee, GM
      Overexpression of bcl-2 inhibits sodium butyrate-induced apoptosis in Chinese hamster ovary cells resulting in enhanced humanized antibody production

      BIOTECHNOLOGY AND BIOENGINEERING
    19. Isaacs, JD; Greer, S; Sharma, S; Symmons, D; Smith, M; Johnston, J; Waldmann, H; Hale, G; Hazleman, BL
      Morbidity and mortality in rheumatoid arthritis patients with prolonged and profound therapy-induced lymphopenia

      ARTHRITIS AND RHEUMATISM
    20. Ryu, DDY; Nam, DH
      Recent progress in biomolecular engineering

      BIOTECHNOLOGY PROGRESS
    21. Hong, HJ; Lee, JW; Park, SS; Kang, YJ; Chang, SY; Kim, KM; Kim, JO; Murthy, KK; Payne, JS; Yoon, SK; Park, MJ; Kim, IC; Kim, JG; Kang, CY
      A humanized anti-4-1BB monoclonal antibody suppresses antigen-induced humoral immune response in nonhuman primates

      JOURNAL OF IMMUNOTHERAPY
    22. DeVincenzo, JP
      Respiratory syncytial virus infections in hematopoietic stem cell transplant recipients and other severely immunocompromised patients

      PEDIATRIC PATHOLOGY & MOLECULAR MEDICINE
    23. Meanwell, NA; Krystal, M
      Respiratory syncytial virus: recent progress towards the discovery of effective prophylactic and therapeutic agents

      DRUG DISCOVERY TODAY
    24. Shigeta, S
      Recent progress in antiviral chemotherapy for respiratory syncytial virus infections

      EXPERT OPINION ON INVESTIGATIONAL DRUGS
    25. Robinson, RF; Nahata, MC
      Respiratory syncytial virus (RSV) immune globulin and palivizumab for prevention of RSV infection

      AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
    26. Takai, T; Yuuki, T; Ra, C
      Inhibition of IgE-dependent histamine release from human peripheral blood basophils by humanized Fab fragments that recognize the membrane proximal domain of the human Fc epsilon RI alpha-chain

      INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY
    27. Goebel, J; Stevens, E; Forrest, K; Roszman, TL
      Daclizumab (Zenapax (R)) inhibits early interleukin-2 receptor signal transduction events

      TRANSPLANT IMMUNOLOGY
    28. Ekberg, H; Backman, L; Tufveson, G; Tyden, G; Nashan, B; Vincenti, F
      Daclizumab prevents acute rejection and improves patient survival post transplantation: 1 year pooled analysis

      TRANSPLANT INTERNATIONAL
    29. Stirling, RG; Chung, KF
      New immunological approaches and cytokine targets in asthma and allergy

      EUROPEAN RESPIRATORY JOURNAL
    30. Keller, MA; Stiehm, ER
      Passive immunity in prevention and treatment of infectious diseases

      CLINICAL MICROBIOLOGY REVIEWS
    31. Sanchez, PJ
      Immunoprophylaxis of respiratory syncytial virus disease

      PEDIATRIC INFECTIOUS DISEASE JOURNAL
    32. Carbonell-Estrany, X; Quero, J; Bustos, G; Cotero, A; Domenech, E; Figueras-Aloy, J; Fraga, JM; Garcia, LG; Garcia-Alix, A; Del Rio, MG; Krauel, X; Sastre, JBL; Narbona, E; Roques, V; Hernandez, SS; Zapatero, M
      Rehospitalization because of respiratory syncytial virus infection in premature infants younger than 33 weeks of gestation: a prospective study

      PEDIATRIC INFECTIOUS DISEASE JOURNAL
    33. Sorbera, LA; Martin, L; Leeson, PA
      CDP-571 - Treatment of IBD anti-TNF-alpha MAb

      DRUGS OF THE FUTURE
    34. Kneyber, MCJ; Moll, HA; de Groot, R
      Treatment and prevention of respiratory syncytial virus infection

      EUROPEAN JOURNAL OF PEDIATRICS
    35. Forre, O; Haugen, M; Hassfeld, WG
      New treatment possibilities in rheumatoid arthritis

      SCANDINAVIAN JOURNAL OF RHEUMATOLOGY
    36. DeVincenzo, JP; Hirsch, RL; Fuentes, RJ; Top, FH
      Respiratory syncytial virus immune globulin treatment of lower respiratorytract infection in pediatric patients undergoing bone marrow transplantation - a compassionate use experience

      BONE MARROW TRANSPLANTATION
    37. Glennie, MJ; Johnson, PWM
      Clinical trials of antibody therapy

      IMMUNOLOGY TODAY
    38. Sawyer, LA
      Antibodies for the prevention and treatment of viral diseases

      ANTIVIRAL RESEARCH
    39. Nakamura, K; Tanaka, Y; Fujino, I; Hirayama, N; Shitara, K; Hanai, N
      Dissection and optimization of immune effector functions of humanized anti-ganglioside GM2 monoclonal antibody

      MOLECULAR IMMUNOLOGY
    40. Davis, TA
      Monoclonal antibody-eased therapy of lymphoid neoplasms: What's on the horizon?

      SEMINARS IN HEMATOLOGY
    41. Cornez, N; Piccart, MJ
      Breast cancer and Herceptin

      BULLETIN DU CANCER
    42. Sauer, PW; Burky, JE; Wesson, MC; Sternard, HD; Qu, L
      A high-yielding, generic fed-batch cell culture process for production of recombinant antibodies

      BIOTECHNOLOGY AND BIOENGINEERING
    43. Kroot, EJJA; van de Putte, LBA; van Riel, PLCM
      Management of therapy-resistant rheumatoid arthritis

      BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY
    44. Prince, GA
      Respiratory syncytial virus antiviral agents

      EXPERT OPINION ON THERAPEUTIC PATENTS
    45. Albanell, J; Baselga, J
      The ErbB receptors as targets for breast cancer therapy

      JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA
    46. Dinant, HJ; Dijkmans, BAC
      New therapeutic targets for rheumatoid arthritis

      PHARMACY WORLD & SCIENCE
    47. Weltzin, R; Monath, TP
      Intranasal antibody prophylaxis for protection against viral disease

      CLINICAL MICROBIOLOGY REVIEWS
    48. Resch, B; Muller, W
      Prophylaxis of respiratory syncytial virus (RSV) infection in preterm infants with/without bronchopulmonary dysplasia: hyperimmune globulin (RSV-IGIV) and pavlivizumab (MEDI-493)

      KLINISCHE PADIATRIE
    49. Kaku, S; Umemura, K; Yano, S; Suzuki, K; Kawasaki, T; Nakashima, M
      YM337, a platelet glycoprotein IIb/IIIa antagonist, lessens photochemically-induced ischemic brain damage in monkeys

      DRUG DEVELOPMENT RESEARCH
    50. Jurianz, K; Maslak, S; Garcia-Schuler, H; Fishelson, Z; Kirschfink, M
      Neutralization of complement regulatory proteins augments lysis of breast carcinoma cells targeted with rhumAb anti-HER2

      IMMUNOPHARMACOLOGY
    51. Canfield, SD; Simoes, EAF
      Prevention of respiratory syncytial virus (RSV) infection: RSV immune globulin intravenous and palivizumab

      PEDIATRIC ANNALS
    52. Yocum, DE
      The role of T-cells in rheumatoid arthritis and the use of immunomodulating drugs

      DRUGS OF TODAY
    53. Prober, CG; Sullender, WM
      Advances in prevention of respiratory syncytial virus infections

      JOURNAL OF PEDIATRICS
    54. Chen, Y; Wiesmann, C; Fuh, G; Li, B; Christinger, HW; McKay, P; de Vos, AM; Lowman, HB
      Selection and analysis of an optimized anti-VEGF antibody: Crystal structure of an affinity-matured Fab in complex with antigen

      JOURNAL OF MOLECULAR BIOLOGY
    55. Gilliland, LK; Walsh, LA; Frewin, MR; Wise, MP; Tone, M; Hale, G; Kioussis, D; Waldmann, H
      Elimination of the immunogenicity of therapeutic antibodies

      JOURNAL OF IMMUNOLOGY
    56. Nagahira, K; Fukuda, Y; Oyama, Y; Kurihara, T; Nasu, T; Kawashima, H; Noguchi, C; Oikawa, S; Nakanishi, T
      Humanization of a mouse neutralizing monoclonal antibody against tumor necrosis factor-alpha (TNF-alpha)

      JOURNAL OF IMMUNOLOGICAL METHODS
    57. Wiseman, LR; Faulds, D
      Daclizumab - A review of its use in the prevention of acute rejection in renal transplant recipients

      DRUGS
    58. Scott, LJ; Lamb, HM
      Palivizumab

      DRUGS
    59. Tokuda, Y; Watanabe, T; Omuro, Y; Ando, M; Katsumata, N; Okumura, A; Ohta, M; Fujii, H; Sasaki, Y; Niwa, T; Tajima, T
      Dose escalation and pharmacokinetic study of a humanized anti-HER2 monoclonal antibody in patients with HER2/neu-overexpressing metastatic breast cancer

      BRITISH JOURNAL OF CANCER
    60. Kim, EJ; Kim, NS; Lee, GM
      Development of a serum-free medium for the production of humanized antibody from Chinese hamster ovary cells using a statistical design

      IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY-ANIMAL
    61. ESCOBAR NI; MORALES AM; DUCONGE J; TORRES IC; FERNANDEZ E; GOMEZ JA
      PHARMACOKINETICS, BIODISTRIBUTION AND DOSIMETRY OF TC-99M-LABELED ANTI-HUMAN EPIDERMAL GROWTH-FACTOR RECEPTOR HUMANIZED MONOCLONAL-ANTIBODYR3 IN RATS

      Nuclear medicine and biology
    62. WALDMANN TA; OSHEA J
      THE USE OF ANTIBODIES AGAINST THE IL-2 RECEPTOR IN TRANSPLANTATION

      Current opinion in immunology
    63. WALLIS WJ; FURST DE; STRAND V; KEYSTONE E
      BIOLOGIC AGENTS AND IMMUNOTHERAPY IN RHEUMATOID-ARTHRITIS - PROGRESS AND PERSPECTIVE

      Rheumatic diseases clinics of North America
    64. STEBBINGS R; STOTT J; ALMOND N; HULL R; LINES E; SILVERA P; SANGSTER R; CORCORAN T; ROSE J; COBBOLD S; GOTCH F; MCMICHAEL A; WALKER B
      MECHANISMS OF PROTECTION INDUCED BY ATTENUATED SIMIAN IMMUNODEFICIENCY VIRUS II - LYMPHOCYTE DEPLETION DOES NOT ABROGATE PROTECTION

      AIDS research and human retroviruses
    65. KINGSBURY GA; WALDMANN TA; JUNGHANS RP
      EXAMINATION OF A ROLE FOR IDIOTYPY IN THE DISEASE REMISSION OF A LONG-TERM SURVIVOR ADULT T-CELL LEUKEMIA TREATED WITH ANTI-TAC ANTIBODY

      Leukemia
    66. THURMOND LM; REESE MJ; DONALDSON RJ; ORBAN BS
      A KINETIC ENZYME-IMMUNOASSAY FOR THE QUANTITATION OF ANTIBODIES TO A HUMANIZED MONOCLONAL-ANTIBODY IN HUMAN SERUM

      Journal of pharmaceutical and biomedical analysis
    67. STRAND V
      FUTURE USE OF BIOLOGIC AGENTS ALONE AND IN COMBINATION FOR THE TREATMENT OF RHEUMATOID-ARTHRITIS

      Zeitschrift fur Rheumatologie
    68. SHINKURA H; IMAZEKI I; YAMAZAKI M; ODA Y; KOTOH M; MIHARA M
      IN-VIVO BLOCKING EFFECTS OF A HUMANIZED ANTIBODY TO HUMAN INTERLEUKIN-6 RECEPTOR ON INTERLEUKIN-6 FUNCTION IN PRIMATES

      Anticancer research
    69. HAGG DS; JUNGHANS RP
      MEASUREMENT AND BIOLOGICAL CORRELATES OF ANTIBODY BIOACTIVITY DURING ANTIBODY IMMUNOTHERAPIES

      Journal of immunological methods
    70. KAKU S; UMEMURA K; MIZUNO A; YANO S; SUZUKI K; KAWASAKI T; NAKASHIMA M
      EVALUATION OF A GPIIB IIIA ANTAGONIST YM337 IN A PRIMATE MODEL OF MIDDLE CEREBRAL-ARTERY THROMBOSIS/

      European journal of pharmacology
    71. BODE C; NORDT TK; PETER K; RUEF J; RUNGE MS; KUBLER W
      TARGETING OF THROMBOLYTIC AND ANTITHROMBOTIC AGENTS

      Fibrinolysis & proteolysis
    72. QU ZX; SHARKEY RM; HANSEN HJ; GOLDENBERG DM; LEUNG S
      STRUCTURE DETERMINATION OF N-LINKED OLIGOSACCHARIDES ENGINEERED AT THE CH1 DOMAIN OF HUMANIZED LL2

      Glycobiology
    73. SCHNITZER TJ; YOCUM DE; MICHALSKA M; BALIUS R; SNIDER ME; HAYS A; THURMOND LM; JOHNSTON JM
      SUBCUTANEOUS ADMINISTRATION OF CAMPATH(R)-1H - CLINICAL AND BIOLOGICAL OUTCOMES

      Journal of rheumatology
    74. SHINKURA H; IMAZEKI I; FUKUSHIMA N; CHIBA N; TAKAHASHI F; AIKAWA H; KITAMURA H; FURUICHI T; HORIBA N; OHSUGI Y
      SAFETY AND KINETIC-PROPERTIES OF A HUMANIZED ANTIBODY TO HUMAN INTERLEUKIN-6 RECEPTOR IN HEALTHY NONHUMAN-PRIMATES

      Toxicology
    75. ROUTIER FH; DAVIES MJ; BERGEMANN K; HOUNSELL EF
      THE GLYCOSYLATION PATTERN OF A HUMANIZED IGGI ANTIBODY (D1.3) EXPRESSED IN CHO CELLS

      Glycoconjugate journal
    76. MOCIKAT R; THIERFELDER S
      ANTIBODY ENGINEERING TECHNIQUES IN TUMORI MMUNOTHERAPY

      Die medizinische Welt
    77. WONG RL; MYTYCH D; JACOBS S; BORDENS R; SWANSON SJ
      VALIDATION PARAMETERS FOR A NOVEL BIOSENSOR ASSAY WHICH SIMULTANEOUSLY MEASURES SERUM CONCENTRATIONS OF A HUMANIZED MONOCLONAL-ANTIBODY ANDDETECTS INDUCED ANTIBODIES

      Journal of immunological methods
    78. ZHOU WC; CHEN CC; BUCKLAND B; AUNINS J
      FED-BATCH CULTURE OF RECOMBINANT NS0 MYELOMA CELLS WITH HIGH MONOCLONAL-ANTIBODY PRODUCTION

      Biotechnology and bioengineering
    79. MCQUEEN FM
      THE USE OF BIOLOGICS IN THE TREATMENT OF RHEUMATOID-ARTHRITIS (RA) - THE GOOD-NEWS AND THE BAD-NEWS

      Australian and New Zealand Journal of Medicine
    80. MORELAND LW; HECK LW; KOOPMAN WJ
      BIOLOGIC AGENTS FOR TREATING RHEUMATOID-ARTHRITIS - CONCEPTS AND PROGRESS

      Arthritis and rheumatism
    81. GEORGE AJT; EPENETOS AA
      ADVANCES IN ANTIBODY ENGINEERING

      Expert opinion on therapeutic patents
    82. WALDMANN TA
      THE PROMISCUOUS IL-2 IL-15 RECEPTOR - A TARGET FOR IMMUNOTHERAPY OF HTLV-I-ASSOCIATED DISORDERS/

      Journal of acquired immune deficiency syndromes and human retrovirology
    83. TSUNENARI T; AKAMATSU K; KAIHO SI; SATO K; TSUCHIYA M; KOISHIHARA Y; KISHIMOTO T; OHSUGI Y
      THERAPEUTIC POTENTIAL OF HUMANIZED ANTI-INTERLEUKIN-6 RECEPTOR ANTIBODY - ANTITUMOR-ACTIVITY IN XENOGRAFT MODEL OF MULTIPLE-MYELOMA

      Anticancer research
    84. THOMAS TC; ROLLINS SA; ROTHER RP; GIANNONI MA; HARTMAN SL; ELLIOTT EA; NYE SH; MATIS LA; SQUINTO SP; EVANS MJ
      INHIBITION OF COMPLEMENT ACTIVITY BY HUMANIZED ANTI-C5 ANTIBODY AND SINGLE-CHAIN FV

      Molecular immunology
    85. TOKUDA Y; OHNISHI Y; SHIMAMURA K; IWASAWA M; YOSHIMURA M; UEYAMA Y; TAMAOKI N; TAJIMA T; MITOMI T
      IN-VITRO AND IN-VIVO ANTITUMOR EFFECTS OF A HUMANIZED MONOCLONAL-ANTIBODY AGAINST C-ERBB-2 PRODUCT

      British Journal of Cancer
    86. KEEN MJ; HALE C
      THE USE OF SERUM-FREE MEDIUM FOR THE PRODUCTION OF FUNCTIONALLY ACTIVE HUMANIZED MONOCLONAL-ANTIBODY FROM NSO MOUSE MYELOMA CELLS ENGINEERED USING GLUTAMINE-SYNTHETASE AS A SELECTABLE MARKER

      Cytotechnology
    87. HABER E
      NEW FIBRINOLYTIC AGENTS - FUTURE-DEVELOPMENTS

      Fibrinolysis
    88. POUL MA; TICCHIONI M; BERNARD A; LEFRANC MP
      INHIBITION OF T-CELL ACTIVATION WITH A HUMANIZED ANTI-BETA-1 INTEGRINCHAIN MAB

      Molecular immunology
    89. STEINER K; HAUNSCHILD J; FARO HP; SENEKOWITSCH R
      DISTRIBUTION OF HUMANIZED MAB-425 (EMD-62000) IN RATS AND SPECIFIC LOCALIZATION IN TUMOR-BEARING NUDE-MICE

      Cellular and molecular biology
    90. KAKU S; KAWASAKI T; SAKAI Y; TANIUCHI Y; YANO S; SUZUKI K; TERAZAKI C; KAWAMURA K; MASUHO Y; SATOH N; TAKENAKA T; YANAGI K; OHSHIMA N
      ANTITHROMBOTIC EFFECT OF A HUMANIZED ANTI-GPIIB IIIA MONOCLONAL-ANTIBODY, YM207, IN A PHOTOCHEMICALLY INDUCED THROMBOSIS MODEL IN MONKEYS/

      European journal of pharmacology
    91. WALDMANN TA; WHITE JD; CARRASQUILLO JA; REYNOLDS JC; PAIK CH; GANSOW OA; BRECHBIEL MW; JAFFE ES; FLEISHER TA; GOLDMAN CK; TOP LE; BAMFORD R; ZAKNOEN S; ROESSLER E; KASTENSPORTES C; ENGLAND R; LITOU H; JOHNSON JA; JACKSONWHITE T; MANNS A; HANCHARD B; JUNGHANS RP; NELSON DL
      RADIOIMMUNOTHERAPY OF INTERLEUKIN-2R-ALPHA-EXPRESSING ADULT T-CELL LEUKEMIA WITH YTTRIUM-90-LABELED ANTI-TAC

      Blood
    92. SHA YH; XIANG J
      A HEAVY-CHAIN GRAFTED ANTIBODY THAT RECOGNIZES THE TUMOR-ASSOCIATED TAG72 ANTIGEN

      Cancer biotherapy
    93. WALDMANN TA
      LYMPHOKINE RECEPTORS - A TARGET FOR IMMUNOTHERAPY OF LYMPHOMAS

      Annals of oncology
    94. NAKATANI T; LONE YC; YAMAKAWA J; KANAOKA M; GOMI H; WIJDENES J; NOGUCHI H
      HUMANIZATION OF MOUSE ANTI-HUMAN IL-2 RECEPTOR ANTIBODY B-B10

      Protein engineering
    95. BOGERS WMJM; LANG F; PARKER KE; LEMAUFF B; ANEGON I; JACQUES Y; SOULILLOU JP
      RAT INTERLEUKIN-2 IMMUNOGLOBULIN-M FUSION PROTEINS ARE CYTOTOXIC IN-VITRO FOR CELLS EXPRESSING THE IL-2 RECEPTOR AND CAN ABOLISH CELL-MEDIATIED IMMUNITY IN-VIVO

      Transplantation
    96. BOGERS WMJM; LANG F; PARKER KE; LEMAUFF B; ANEGON I; JACQUES Y; SOULILLOU JP
      RAT INTERLEUKIN-2 IMMUNOGLOBULIN-M FUSION PROTEINS ARE CYTOTOXIC IN-VITRO FOR CELLS EXPRESSING THE IL-2 RECEPTOR AND CAN ABOLISH CELL-MEDIATIED IMMUNITY IN-VIVO

      Transplantation
    97. KITAMURA K; STOCKERT E; GARINCHESA P; WELT S; LLOYD KO; ARMOUR KL; WALLACE TP; HARRIS WJ; CARR FJ; OLD LJ
      SPECIFICITY ANALYSIS OF BLOOD-GROUP LEWIS-Y (LE(Y)) ANTIBODIES GENERATED AGAINST SYNTHETIC AND NATURAL LE(Y) DETERMINANTS

      Proceedings of the National Academy of Sciences of the United Statesof America
    98. PIMM MV
      POSSIBLE CONSEQUENCES OF HUMAN-ANTIBODY RESPONSES ON THE BIODISTRIBUTION OF FRAGMENTS OF HUMAN, HUMANIZED OR CHIMERIC MONOCLONAL-ANTIBODIES- A NOTE OF CAUTION

      Life sciences
    99. CORTI A; BARBANTI E; TEMPEST PR; CARR FJ; MARCUCCI F
      IDIOTOPE DETERMINING REGIONS OF A MOUSE MONOCLONAL-ANTIBODY AND ITS HUMANIZED VERSIONS - IDENTIFICATION OF FRAMEWORK RESIDUES THAT AFFECT IDIOTYPE EXPRESSION

      Journal of Molecular Biology
    100. FEI DTW; LOWE J; JARDIEU P
      A NOVEL BIOACTIVITY ASSAY FOR MONOCLONAL-ANTIBODIES DIRECTED AGAINST IGE

      Journal of immunological methods


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 11/08/20 alle ore 05:46:07